Enabling Scalable Circular RNA Manufacturing Through Optimized Purification and Characterisation Strategies
- What are the most persistent challenges you face in reducing dsRNA impurities, and where are current purification approaches falling short?
- How are you balancing regulatory expectations for low impurity levels with the technical limitations of existing purification technologies?
- Which purification strategies, platforms, or resins have shown the most promise, and where do gaps still remain?